OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I/II study of GC1008: A human anti-transforming growth factor-beta (TGFβ) monoclonal antibody (MAb) in patients with advanced malignant melanoma (MM) or renal cell carcinoma (RCC)

HTML

Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2008.26.15_suppl.9028
Authors: J. C. Morris, G. I. Shapiro, A. R. Tan, D. P. Lawrence, T. E. Olencki, B. J. Dezube, F. J. Hsu, M. Reiss, J. A. Berzofsky
Language: English

Topic: TGF-β signaling in diseases
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: TGF-beta, melanoma, renal cell carcinoma, TGF-beta signaling, dose-limiting toxicity, treatment efficacy and safety, TGF-beta neutralization, advanced cancer, rash, cutaneous squamous cell carcinoma, extended treatment, tumor response, antitumor immunity, angiogenesis
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2306753419
Cites:
Cited by: 87
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security